Aquiant Research Clinical Trial Phases Drops

Clinical Trial Phases


When a new medication or procedure is being investigated in a clinical study, research typically proceeds through four distinct phases. Participants in any study conducted by Aquiant Research will be informed as to which phase is being conducted for the particular study in which they are participating.


Phase I: Performed with a small group of people (20-80) to evaluate safety and identify side effects.


Phase II: Performed with a larger group (100-300) to determine effectiveness and to further evaluate safety.


Phase III: Administered to large groups (1,000-3,000) to confirm effectiveness, monitor side effects, compare it with other treatments, and collect information that will allow it to be used safely.


Phase IV: After FDA approval and release to the public, researchers track its use to learn more about risks, benefits, and optimal use.


To learn more or volunteer for a study, call 812.206.1702 or email dwalker@aquiant.com.